Jiangsu Hengrui Medicine Co Ltd 2022 SR

The report highlights Jiangsu Hengrui Pharmaceuticals' sustainability progress in 2022, focusing on innovation, green development, and social responsibility. The company invested RMB 6.346 billion in R&D, representing 29.83% of its revenue, and achieved marketing approval for 12 innovative drugs. Environmental efforts included passing ISO 50001 certification and reducing total greenhouse gas emissions to 203,512.91 t CO2e. Socially, the company launched the 'With All Your Love' patient care brand and donated RMB 30 million to the 'Health Assistance' program for rural revitalization. Governance was strengthened through enhanced compliance systems and a jump in the MSCI ESG rating from B to BBB.

Company: Jiangsu Hengrui Medicine Co Ltd

Sector: Health Care

Country: China

Year: 2022

Type: SR

Pages: 57

Back to company

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Hengrui Medicine Co Ltd 2022 ESG Report

ESG Report

The report highlights Jiangsu Hengrui Pharmaceuticals' sustainability progress in 2022, focusing on innovation, green development, and social responsibility. The company invested RMB 6.346 billion in R&D, representing 29.83% of its revenue, and achieved marketing approval for 12 innovative drugs. Environmental efforts included passing ISO 50001 certification and reducing total greenhouse gas emissions to 203,512.91 t CO2e. Socially, the company launched the 'With All Your Love' patient care brand and donated RMB 30 million to the 'Health Assistance' program for rural revitalization. Governance was strengthened through enhanced compliance systems and a jump in the MSCI ESG rating from B to BBB.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2022

Reporting Period

Jan 1, 2022 - Dec 31, 2022

Fiscal Year

2022

Published

Apr 20, 2023

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Other Standards

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Water Consumption

Total Waste

Women on Board

Women in Management

Net Zero Target

Employees